吸脂术与保守治疗对德国脂肪水肿患者的疗效比较:多中心随机对照临床试验
该多中心随机对照试验纳入410例I-III期脂肪水肿女性患者,随机分至吸脂术组(278例)或保守治疗组(132例)。吸脂术在减轻疼痛和改善生活质量方面优于保守治疗,但严重不良事件发生率更高。
要点
- 吸脂术组12个月疼痛缓解率达68%,显著高于保守治疗组的8%。
- 吸脂术组不良事件发生率47%,严重不良事件8%;保守治疗组分别为21%和3%。
- 吸脂术可作为脂肪水肿患者的潜在治疗选择,但需权衡安全性。
核心结论
- 吸脂术在减轻腿痛和改善生活质量方面优于保守治疗,但严重不良事件发生率更高。
研究设计与样本
- 多中心随机对照试验,在德国11个中心进行,纳入410例I-III期脂肪水肿女性患者,按2:1随机分配至吸脂术组(278例)或保守治疗组(132例),按疾病分期和研究中心分层。
主要发现
- 吸脂术组不良事件发生率为47%(124/265),其中严重不良事件8%(20/265);保守治疗组不良事件发生率21%(30/145),严重不良事件3%(5/145)。
- 生活质量次要终点显示吸脂术组改善更明显。
临床怎么用
- 对于I-III期脂肪水肿女性患者,吸脂术可显著减轻腿痛并改善生活质量,但需告知患者严重不良事件风险较高。
局限性
- 36个月长期随访仍在进行中,目前仅报告12个月结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lipoedema is a painful, chronic disease of the subcutaneous adipose tissue, predominantly affecting women. Conservative complex decongestive therapy is the standard of care but offers limited symptom relief. Liposuction appears to be a promising approach but lacks evidence of effectiveness and safety. The aim of this trial was to show superiority of liposuction compared with conservative therapy regarding relevant pain reduction with reasonable safety. METHODS: In this multicentre, randomised controlled trial at 11 German centres, eligible women with stage I, II, or III lipoedema and leg pain of at least 4 points on a 0-10 numeric rating scale received conservative therapy for up to 7 months and then were randomly assigned to liposuction or conservative therapy (2:1) stratified by lipoedema stage and study site. For all visits involving an assessment, patches were applied to the legs of all patients, and patients were instructed not to reveal the treatment they had received, in order to mask the assessor. The primary endpoint was reduction of patient-reported leg pain by at least 2 points after 12 months, and missing assessment was considered non-successful.The primary outcome was analysed in the intention-to-treat population which included all randomly assigned patients, and safety analysis included all enrolled patients. A long-term follow-up of 36 months is ongoing. This study is registered at ClinicalTrials.gov, NCT04272827. FINDINGS: Of 1973 patients screened between Jan 19, 2021, and June 7, 2022, 453 were enrolled, and 410 were randomly assigned to the liposuction group (n=278) or to the conservative therapy group (n=132). All 410 patients were included in the intention-to-treat analysis (mean age 42·9 [ SD 10·6]; ethnicity data were not collected). After 12 months, 190 (68%) of 278 randomisly assigned patients undergoing liposuction achieved the primary endpoint of pain reduction versus ten (8%) of 132 randomly assigned to conservative therapy (odds ratio 26·2 [95% CI 13·1-52·5]; p<0·0001). Adverse events occurred in 124 (47%) of 265 patients undergoing liposuction, and 20 (8%) of 265 were rated as serious. In the conservative therapy group, 30 (21%) of 145 patients reported adverse events, and five (3%) 145 were rated as serious. Secondary endpoints regarding quality of life showed greater improvement in the liposuction group. INTERPRETATION: Liposuction was superior to conservative therapy in reducing leg pain and improving quality of life in patients with lipoedema, but was associated with a higher rate of serious adverse events. Liposuction has the potential to be a promising treatment option for patients with lipoedema. FUNDING: The Federal Joint Committee, Germany.
引用
- Podda M, Schmidt J, Cornely ME, et al. Liposuction versus conservative therapy for patients with lipoedema in Germany: a multicentre, randomised controlled clinical trial. Lancet. 2026. PMID: 42692034. doi:10.1016/S0140-6736(26)00910-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。